Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by foofadoooon Feb 01, 2018 12:18pm
277 Views
Post# 27480499

RE:RE:just re listened to the webcast

RE:RE:just re listened to the webcastWe have 15 to 18 papers to follow...the first of which will be available mid February. I don’t expect to see a lot happen News wise before. A partnership cannot be far off ....I would bet SERIOUS negotiations are now underway. Hobnobbing is still going on to be happening today...investment houses will glean all they can both from Prometic and potential partners....prepare for take off...just my honest opinion....we have a miracle drug ....realization is just setting in.  foof
Bullboard Posts